Literature DB >> 9763304

Alpha-MSH regulates interleukin-10 expression by human keratinocytes.

P Redondo1, J García-Foncillas, I Okroujnov, E Bandrés.   

Abstract

Normal human keratinocytes (HKC) are able to synthesize alpha-MSH. Because the production of alpha-MSH by HKC is induced significantly by ultraviolet B radiation, the involvement of keratinocyte-derived alpha-MSH in UV-induced immunosuppression has been suggested. The induction of the antiinflammatory cytokine IL-10 in monocytes is a major mechanism in the antiinflammatory actions of alpha-MSH. In the present study, HKC were investigated for their ability to produce IL-10 after alpha-MSH stimulation. HKC were obtained from the skin of human female breast sections and either left untreated or treated with 0.01 or 0.1 microg/ml alpha-MSH for different times. Using RT-PCR, HKC were shown to express IL-10 mRNA even under basal conditions, and treatment with alpha-MSH increased expression. Only minimal concentrations of IL-10 protein were detected in supernatants from the alpha-MSH-stimulated cultures. To the best of our knowledge this is the first report of IL-10 expression by cultured HKC after alpha-MSH stimulation. Further studies are needed to determine the biological and therapeutic relevance of these findings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763304     DOI: 10.1007/s004030050330

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Spatial and temporal localization of the melanocortin 1 receptor and its ligand α-melanocyte-stimulating hormone during cutaneous wound repair.

Authors:  Lara A Muffley; Kathy Q Zhu; Loren H Engrav; Nicole S Gibran; Anne M Hocking
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

Review 3.  Hypertrophic Scarring: Current Knowledge of Predisposing Factors, Cellular and Molecular Mechanisms.

Authors:  Layla Nabai; Amir Pourghadiri; Aziz Ghahary
Journal:  J Burn Care Res       Date:  2020-01-30       Impact factor: 1.845

4.  Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.

Authors:  Heesung Chung; Jung-hyun Lee; Dayun Jeong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

5.  Anti-inflammatory influences on behavioral, but not cortisol, responses during maternal separation.

Authors:  Allison M Perkeybile; Patricia A Schiml-Webb; Erin O'Brien; Terrence Deak; Michael B Hennessy
Journal:  Psychoneuroendocrinology       Date:  2009-03-25       Impact factor: 4.905

Review 6.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

7.  A multimodal assessment of melanin and melanocyte activity in abnormally pigmented hypertrophic scar.

Authors:  Taryn E Travis; Pejhman Ghassemi; Jessica C Ramella-Roman; Nicholas J Prindeze; Dereck W Paul; Lauren T Moffatt; Marion H Jordan; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

Review 8.  Photoimmunology.

Authors:  Craig A Elmets; Cather M Cala; Hui Xu
Journal:  Dermatol Clin       Date:  2014-05-05       Impact factor: 3.478

Review 9.  Autonomic nerve dysfunction and impaired diabetic wound healing: The role of neuropeptides.

Authors:  Georgios Theocharidis; Aristidis Veves
Journal:  Auton Neurosci       Date:  2019-11-26       Impact factor: 3.145

Review 10.  Nerve-derived transmitters including peptides influence cutaneous immunology.

Authors:  Elizabeth N Madva; Richard D Granstein
Journal:  Brain Behav Immun       Date:  2013-03-18       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.